
Triomics raises $22 million to streamline cancer care with AI - NewsBytes
Triomics is a company focused on streamlining cancer care through the use of artificial intelligence. Their innovative approach aims to improve patient outcomes and enhance the efficiency of cancer treatment processes. The recent funding will help them further develop their technology and expand their reach in the healthcare market.
Triomics raises $22 million to streamline cancer care with AI NewsBytes
| May 27, 2026 | Protuoso | $9.5M | Seed | United States |
| May 27, 2026 | Ember LifeSciences | $27.0M | Series A | United States |
| May 27, 2026 | Waypoint Bio | $20.0M | — | China |
| May 27, 2026 | Oli | $6.5M | Series A | Australia |